Nubeqa® approved by the US Food and Drug Administration
FDA approves Nubeqa (darolutamide) as a new treatment for men with non-metastatic castration-resistant prostate cancer.
List view / Grid view
News
Pharmaceutical robots market to see significant growth
The global pharmaceutical robots market is set to be worth $344.4m at the end of a forecast period, after seeing substantial growth.
Brand-brand competition will not reduce prices of drugs in US
A new study undertaken to better understand the economic impact of brand-brand competition finds this does not lower drug prices.
Trump drafts plan to import drugs from Canada
In another bid to lower medication prices in the US, Donald Trump has announced a draft plan to import drugs from Canada.
First UK national pilot study for medical cannabis launched
Project TWENTY21, a nationwide study to investigate medicinal cannabis, has launched in the UK in order to collect data on the therapeutics.
Eurofins Alphora and Eurofins Amatsigroup announce company rebrand to Eurofins CDMO
The commercial brand for Eurofins Alphora and Eurofins Amatsigroup is now Eurofins CDMO (Contract Development Manufacturing Organization).
AstraZeneca and Novartis set to lose out from US drug prices reforms
A report has suggested that the drug price reforms in the US will affect AstraZeneca and Novartis negatively, but Novo could benefit.
Cannabidiol-based treatment receives marketing approval from EMA
EMA’s human medicines committee had cleared the cannabidiol oral solution, Epidiolex, for use to treat seizures.
Pharma companies to pay California $70m for drug delays
Teva Pharmaceuticals, Endo Pharmaceuticals and Teikoku will pay almost $70 million to the US state for delaying drugs to keep prices high.
PharmaLab 2019 – In times of changes
For the 7th time, PharmaLab, picks up the latest developments in regulations, quality control and assurance and in laboratory methods and systems.
Microrobots could be used to deliver drugs inside the body
Scientists have developed microrobots that can deliver medication to specific spots inside the body while being controlled from outside the patient.
EMA recommends Vitrakvi for EU marketing authorisation
The EMA has announced its approval for marketing authorisation in the EU for Vitrakvi (larotrectinib), used to treat solid tumours with a specific gene mutation.
Three pharma companies accused of breaking competition law
The CMA alleges that a pharmaceutical company agreed to buy equal quantities of a pill from two drug suppliers, breaking competition law.
Pharma processing and packaging equipment market to see growth
The pharmaceutical processing and packaging equipment market is expected to witness a high increase during the forecast period (2019-2025).
Roche confirms cyber-attack from Winnti malware
The pharmaceutical company Roche has affirmed that it was hit by a Winnti cyber-attack, thought to be supported by the Chinese government.
